Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076326089> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2076326089 endingPage "1417" @default.
- W2076326089 startingPage "1409" @default.
- W2076326089 abstract "Basilar-type migraine (BM) is the most common migraine variant, representing 3-19% of migraine in children.BMis characterized by attacks of dizziness, vertigo, visual disturbances, ataxia, and/or diplopia, followed by migraine headache.The objective of this study is to assess the efficacy and safety of topiramate for prophylaxis of BM in children and adolescents (6-18 years).Outpatient, double-blind, parallel-group, dose comparison study with 2 phases: prerandomization (screening/washout and 4-week prospective baseline) and 12-week double blind (titration and maintenance).Following consent and assent, subjects with BMs, as defined by the International Classification of Headache Disorders (second edition), and > or =4 migraines/month were randomized to receive either 25 mg per day or 100 mg per day of topiramate in a 1 : 1 ratio.Fourteen children (4 boys, 10 girls) completed the double-blind phase (7 in the 25-mg group and 7 in the 100-mg group). During the prospective baseline, the mean headache frequency of the combined group all migraines per month was 4.5/month (25 mg) and 4.8/month (100 mg). Average duration of migraine was 5.5 hours (25 mg) and 5.0 hours (100 mg) and average mean pain (5-point faces scale) was 3.3 for both (25 mg 100 mg). The reduction in median monthly migraine rate during the double-blind treatment phase relative to baseline was 2.9 (64.4%) and 3.6 (75.0%) for the 25-mg and 100-mg topiramate-treated groups, respectively (P < .001). The reduction in median monthly BM rate during the double-blind treatment phase relative to baseline was 2.5 (74.24%) and 2.3 (82.8%) for the 25-mg and 100-mg topiramate-treated groups, respectively. The overall reduction in BM attacks reduced from 2.84/month to 0.59/month (79.2%; P < .0042). Overall, 86% of patients responded with a greater than 50% reduction in migraine frequency (100%, 25 mg and 71%, 100 mg). Mean reduction in migraine duration was 18 minutes (25 mg) and 89 minutes (100 mg). There was no significant difference in migraine severity between the 2 groups. Parent Global Assessment was very much or much improved in 6 of 7 (25 mg) and 3 of 7 (100 mg) patients. Migraine disability as measured by PedMidas reduced from moderate to no disability (P < .001). There were no serious adverse events.Preventive therapy with topiramate resulted in reducing the overall migraine frequency and the frequency of attacks of BM at both 25 mg and 100 mg doses relative to the historical baseline and prospective baseline periods. The 2 treatment groups resulted in comparable outcomes." @default.
- W2076326089 created "2016-06-24" @default.
- W2076326089 creator A5036792042 @default.
- W2076326089 creator A5059903481 @default.
- W2076326089 date "2007-11-01" @default.
- W2076326089 modified "2023-10-18" @default.
- W2076326089 title "A Double-Blind, Dose Comparison Study of Topiramate for Prophylaxis of Basilar-Type Migraine in Children: A Pilot Study" @default.
- W2076326089 cites W1969920910 @default.
- W2076326089 cites W1971634866 @default.
- W2076326089 cites W1982468238 @default.
- W2076326089 cites W1985916570 @default.
- W2076326089 cites W2023384436 @default.
- W2076326089 cites W2062526596 @default.
- W2076326089 cites W2068520581 @default.
- W2076326089 cites W2082036575 @default.
- W2076326089 cites W2109212419 @default.
- W2076326089 cites W2126685531 @default.
- W2076326089 cites W2127246721 @default.
- W2076326089 cites W2152007006 @default.
- W2076326089 cites W4206701431 @default.
- W2076326089 doi "https://doi.org/10.1111/j.1526-4610.2007.00867.x" @default.
- W2076326089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18052950" @default.
- W2076326089 hasPublicationYear "2007" @default.
- W2076326089 type Work @default.
- W2076326089 sameAs 2076326089 @default.
- W2076326089 citedByCount "23" @default.
- W2076326089 countsByYear W20763260892013 @default.
- W2076326089 countsByYear W20763260892014 @default.
- W2076326089 countsByYear W20763260892015 @default.
- W2076326089 countsByYear W20763260892016 @default.
- W2076326089 countsByYear W20763260892017 @default.
- W2076326089 countsByYear W20763260892019 @default.
- W2076326089 countsByYear W20763260892020 @default.
- W2076326089 crossrefType "journal-article" @default.
- W2076326089 hasAuthorship W2076326089A5036792042 @default.
- W2076326089 hasAuthorship W2076326089A5059903481 @default.
- W2076326089 hasConcept C118552586 @default.
- W2076326089 hasConcept C187212893 @default.
- W2076326089 hasConcept C2777683783 @default.
- W2076326089 hasConcept C2778186239 @default.
- W2076326089 hasConcept C2778541695 @default.
- W2076326089 hasConcept C42219234 @default.
- W2076326089 hasConcept C71924100 @default.
- W2076326089 hasConceptScore W2076326089C118552586 @default.
- W2076326089 hasConceptScore W2076326089C187212893 @default.
- W2076326089 hasConceptScore W2076326089C2777683783 @default.
- W2076326089 hasConceptScore W2076326089C2778186239 @default.
- W2076326089 hasConceptScore W2076326089C2778541695 @default.
- W2076326089 hasConceptScore W2076326089C42219234 @default.
- W2076326089 hasConceptScore W2076326089C71924100 @default.
- W2076326089 hasIssue "10" @default.
- W2076326089 hasLocation W20763260891 @default.
- W2076326089 hasLocation W20763260892 @default.
- W2076326089 hasOpenAccess W2076326089 @default.
- W2076326089 hasPrimaryLocation W20763260891 @default.
- W2076326089 hasRelatedWork W1506200166 @default.
- W2076326089 hasRelatedWork W1995515455 @default.
- W2076326089 hasRelatedWork W2080531066 @default.
- W2076326089 hasRelatedWork W2107594135 @default.
- W2076326089 hasRelatedWork W2279609684 @default.
- W2076326089 hasRelatedWork W2748952813 @default.
- W2076326089 hasRelatedWork W2899084033 @default.
- W2076326089 hasRelatedWork W3031052312 @default.
- W2076326089 hasRelatedWork W3032375762 @default.
- W2076326089 hasRelatedWork W3108674512 @default.
- W2076326089 hasVolume "47" @default.
- W2076326089 isParatext "false" @default.
- W2076326089 isRetracted "false" @default.
- W2076326089 magId "2076326089" @default.
- W2076326089 workType "article" @default.